- Home
- ICUI vs CAAP Comparison
ICUI vs CAAP Comparison
Compare ICUI & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- CAAP
- Stock Information
- Founded
- ICUI 1984
- CAAP 1998
- Country
- ICUI United States
- CAAP Luxembourg
- Employees
- ICUI N/A
- CAAP N/A
- Industry
- ICUI Medical/Dental Instruments
- CAAP Aerospace
- Sector
- ICUI Health Care
- CAAP Consumer Discretionary
- Exchange
- ICUI Nasdaq
- CAAP Nasdaq
- Market Cap
- ICUI 3.4B
- CAAP 3.3B
- IPO Year
- ICUI 1992
- CAAP 2018
- Fundamental
- Price
- ICUI $127.40
- CAAP $19.54
- Analyst Decision
- ICUI Strong Buy
- CAAP Strong Buy
- Analyst Count
- ICUI 5
- CAAP 2
- Target Price
- ICUI $196.75
- CAAP $24.35
- AVG Volume (30 Days)
- ICUI 186.2K
- CAAP 116.3K
- Earning Date
- ICUI 08-07-2025
- CAAP 08-20-2025
- Dividend Yield
- ICUI N/A
- CAAP N/A
- EPS Growth
- ICUI N/A
- CAAP N/A
- EPS
- ICUI N/A
- CAAP 1.05
- Revenue
- ICUI $2,420,093,000.00
- CAAP $1,858,038,000.00
- Revenue This Year
- ICUI N/A
- CAAP $0.91
- Revenue Next Year
- ICUI N/A
- CAAP $12.63
- P/E Ratio
- ICUI N/A
- CAAP $18.93
- Revenue Growth
- ICUI 7.22
- CAAP 28.46
- 52 Week Low
- ICUI $117.92
- CAAP $13.97
- 52 Week High
- ICUI $196.26
- CAAP $22.13
- Technical
- Relative Strength Index (RSI)
- ICUI 46.81
- CAAP 44.02
- Support Level
- ICUI $124.39
- CAAP $19.50
- Resistance Level
- ICUI $134.04
- CAAP $20.56
- Average True Range (ATR)
- ICUI 3.75
- CAAP 0.52
- MACD
- ICUI 0.18
- CAAP -0.01
- Stochastic Oscillator
- ICUI 47.55
- CAAP 15.69
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.